Abstract
Purpose
The present study aimed to investigate the effects of exercise therapy on delirium in cancer patients.
Methods
We conducted a retrospective study of cancer patients who were admitted to Kyoto University Hospital and referred to the Palliative Care Team. Subjects were divided into two groups [an exercise therapy group (EG) and a non-exercise therapy group (NG)] according to whether exercise therapy was being used for early ambulation at the time delirium occurred. To examine whether any characteristics differed significantly between the two groups, we also compared age, performance status, alcohol use, existence of metastatic brain tumors or preexisting CNS illnesses, levels of opioid exposure, and survival time from the onset of delirium. Moreover, we investigated whether there were differences in antipsychotic drug doses administered between these two groups in order to better analyze the specific effects of exercise therapy on the course of delirium.
Results
EG and NG groups did not differ significantly in terms of any characteristics. The administered dose of antipsychotic drugs was significantly lower in the EG group versus the NG group (2.198 mg versus 5.533 mg, p = 0.036). In comparison, the dose of opioids used did not differ significantly between the two study groups.
Conclusions
Given the relatively low antipsychotic doses used, it is conceivable that delirium symptoms were attenuated in patients who received exercise therapy. This study suggests that exercise therapy may be useful as one environmental/supportive intervention for delirium.
Similar content being viewed by others
References
American Psychiatric Association (1999) Practice guideline for the treatment of patients with delirium. Am J Psychiatry 156:1–20
Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J (1992) Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7:192–195
Bruera E, Schoeller T, Wenk R, MacEachern T, Marcelino S, Hanson J, Suarez-Almazor M (1995) A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage 10:348–355
Caraceni A, Simonetti F (2009) Palliating delirium in patients with cancer. Lancet Oncol 10:164–172
Casarett DJ, Inouye SK (2001) Diagnosis and management of delirium near the end of life. Ann Intern Med 135:32–40
Centeno C, Sanz A, Bruera E (2004) Delirium in advanced cancer patients. Palliat Med 18:184–194
Clouston PD, DeAngelis LM, Posner JB (1992) The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 31:268–273
Duppils G, Wikblad K (2007) Patients' experiences of being delirious. J Clin Nurs 16:810–818
Fuller P, Gooley J, Saper C (2006) Neurobiology of the sleep–wake cycle: sleep architecture, circadian regulation, and regulatory feedback. J Biol Rhythms 21:482–493
Gagnon PR (2008) Treatment of delirium in supportive and palliative care. Curr Opin Support Palliat Care 2:60–66
Inouye S (2006) Delirium in older persons. N Engl J Med 354:1157–1165
Inouye SK (1994) The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 97:278–288
Inouye SK (1998) Delirium in hospitalized older patients: recognition and risk factors. J Geriatr Psychiatry Neurol 11:118–125, discussion 157-118
Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340:669–676
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI (1990) Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 113:941–948
Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED (2000) Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 160:786–794
Ljubisavljevic V, Kelly B (2003) Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 25:345–352
Mackin P (2008) Cardiac side effects of psychiatric drugs. Hum Psychopharmacol 23(Suppl 1):3–14
Massie MJ, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048–1050
Meagher D (2001) Delirium: optimising management. BMJ 322:144–149
Michaud L, Burnand B, Stiefel F (2004) Taking care of the terminally ill cancer patient: delirium as a symptom of terminal disease. Ann Oncol 15(Suppl 4):iv199–203
Milisen K, Lemiengre J, Braes T, Foreman MD (2005) Multicomponent intervention strategies for managing delirium in hospitalized older people: systematic review. J Adv Nurs 52:79–90
Morency CR (1990) Mental status change in the elderly: recognizing and treating delirium. J Prof Nurs 6:356–364, discussion 364–355
Olofsson SM, Weitzner MA, Valentine AD, Baile WF, Meyers CA (1996) A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer 4:351–357
Siddiqi N, Stockdale R, Britton AM, Holmes J (2007) Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev: CD005563
Acknowledgments
The authors wish to acknowledge the contributions of all study participants.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tatematsu, N., Hayashi, A., Narita, K. et al. The effects of exercise therapy on delirium in cancer patients: a retrospective study. Support Care Cancer 19, 765–770 (2011). https://doi.org/10.1007/s00520-010-0874-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-010-0874-1